Pharmaceutical

Alvotech and Dr Reddy’s partner to commercialise AVT03

Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the commercialisation of AVT03 in the US, Europe and the UK.

May 23, 2024 - 04:00
Alvotech and Dr Reddy’s partner to commercialise AVT03
Alvotech has entered into a collaboration with Dr. Reddy's Laboratories for the commercialisation of AVT03 in the US, Europe and the UK.
Read the original article

Tags:

Previous Article

Genmab acquires biotechnology company ProfoundBio in $1.8bn deal

Next Article

AltruBio secures $225m for immune checkpoint programme development

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition

Lilly bolsters IBD portfolio with $3.2bn Morphic acquis...

Jul 10, 2024

STAT+: Can Wegovy treat depression as well as obesity? New research looks to GLP-1 drugs for mental illnesses

STAT+: Can Wegovy treat depression as well as obesity? ...

Jan 30, 2024

Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions

Signal: Porosome files comprehensive patent for therapi...

Aug 22, 2023